Press releases

Press releases.

Immutep Selects Charles River Laboratories for IMP761’s GLP Toxicology Study

May 29th 2023
press releases

Immutep Announces Publication of Abstracts for ASCO 2023 Annual Meeting

May 26th 2023
press releases

Immutep Doses First Patient in AIPAC-003 Phase II/III Trial for Metastatic Breast Cancer

May 25th 2023
press releases
more

Investor updates

Investor updates.

Investor Update - November 2022

November 17th 2022
investor updates

Investor Update ASCO 2022 Special Edition June 2022

June 17th 2022
investor updates

Investor Update - February 2022

February 18th 2022
investor updates
more

Analyst reports

Analyst reports.

goetzpartners securities - Efti-combo's boost efficacy of lung cancer standard of care; Reit Buy, A$2.88 tgt

This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.

May 29th 2023
analyst reports

Petra Capital - 2L HNSCC detailed results: Wait for ASCO; Retain Buy, A$1.28 tgt (Analyst: Tanushree Jain)

For a copy of this analyst report please contact your Petra advisor

May 29th 2023
analyst reports

Wilsons Equity Research - Final 2L HNSCC data: still doubling ORR; Maintain Overweight (Analysts: Dr Melissa Benson and Dr Shane Storey)

May 26th 2023
analyst reports
more


E-MAIL UPDATES

registration.

Please fill out the registration form below to receive updates and announcements by e-mail.